ABOUT
About MakingLife
About MakingPharmaindustry
Contact us
PUBBLICATIONS
MakingPharmaIndustry
RESEARCH
Clinical research
Technology
MANUFACTURING
BioDrugs & ATMP
Contract manufacturing
GMP
Production lines & equipments
API & Excipients
Packaging
Quality & Validation
PHARMA ENGINEERING by ISPE
Technology
SUPPLEMENTS
REGULATORY
Guidelines
Legislation
Pharmacovigilance
SUPPLY CHAIN
Blockchain
GDP
Artificial intelligence
Logistics
Management
Security and privacy
DIGITAL HEALTH
Medical devices
Telemedicine
Digital Therapies
BUSINESS
EVENTS
Corporate Social Responsibility
Deal & Finance
Digital transformation
Diversity & Inclusion
ESG
Insights
Leadership changes
Leadership lessons
Marketing & Communication
Market
Human resources
Startup
HTA
EIPG NEWS
Search
Search
ABOUT
About MakingLife
About MakingPharmaindustry
Contact us
PUBBLICATIONS
MakingPharmaIndustry
RESEARCH
Clinical research
Technology
MANUFACTURING
BioDrugs & ATMP
Contract manufacturing
GMP
Production lines & equipments
API & Excipients
Packaging
Quality & Validation
PHARMA ENGINEERING by ISPE
Technology
SUPPLEMENTS
REGULATORY
Guidelines
Legislation
Pharmacovigilance
SUPPLY CHAIN
Blockchain
GDP
Artificial intelligence
Logistics
Management
Security and privacy
DIGITAL HEALTH
Medical devices
Telemedicine
Digital Therapies
BUSINESS
EVENTS
Corporate Social Responsibility
Deal & Finance
Digital transformation
Diversity & Inclusion
ESG
Insights
Leadership changes
Leadership lessons
Marketing & Communication
Market
Human resources
Startup
HTA
EIPG NEWS
Home
BioDrugs & ATMP
BioDrugs & ATMP
BioDrugs & ATMP
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
Simone Montonati
-
January 10, 2025
BioDrugs & ATMP
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
BioDrugs & ATMP
Decentralized production of advanced therapies, the Car-T case
BioDrugs & ATMP
Signals of recovery for the ATMP market
BioDrugs & ATMP
62° AFI Symposium – Maria Luisa Nolli’s interview
BioDrugs & ATMP
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
October 4, 2024
BioDrugs & ATMP
Decentralized production of advanced therapies, the Car-T case
September 11, 2024
BioDrugs & ATMP
Signals of recovery for the ATMP market
September 10, 2024
BioDrugs & ATMP
62° AFI Symposium – Maria Luisa Nolli’s interview
May 15, 2023
Linkedin
Instagram
Youtube